US20060008806A1
(en)
*
|
1986-07-17 |
2006-01-12 |
University Of Washington |
Method for producing novel DNA sequence with biological activity
|
US5747334A
(en)
*
|
1990-02-15 |
1998-05-05 |
The University Of North Carolina At Chapel Hill |
Random peptide library
|
US5498538A
(en)
*
|
1990-02-15 |
1996-03-12 |
The University Of North Carolina At Chapel Hill |
Totally synthetic affinity reagents
|
US5639595A
(en)
*
|
1990-05-01 |
1997-06-17 |
Isis Phamaceuticals, Inc. |
Identification of novel drugs and reagents
|
US5874218A
(en)
*
|
1990-06-11 |
1999-02-23 |
Nexstar Pharmaceuticals, Inc. |
Method for detecting a target compound in a substance using a nucleic acid ligand
|
DE69132843T2
(de)
*
|
1990-12-06 |
2002-09-12 |
Affymetrix Inc N D Ges D Staat |
Identifizierung von Nukleinsäuren in Proben
|
US5733731A
(en)
*
|
1991-10-16 |
1998-03-31 |
Affymax Technologies N.V. |
Peptide library and screening method
|
US5270170A
(en)
*
|
1991-10-16 |
1993-12-14 |
Affymax Technologies N.V. |
Peptide library and screening method
|
US6469158B1
(en)
*
|
1992-05-14 |
2002-10-22 |
Ribozyme Pharmaceuticals, Incorporated |
Synthesis, deprotection, analysis and purification of RNA and ribozymes
|
ATE319738T1
(de)
*
|
1992-06-18 |
2006-03-15 |
Creagen Inc |
Verfahren zur herstellung eines sets von kombinatorischen polypeptidantigenen
|
US5840484A
(en)
*
|
1992-07-17 |
1998-11-24 |
Incyte Pharmaceuticals, Inc. |
Comparative gene transcript analysis
|
US6303297B1
(en)
|
1992-07-17 |
2001-10-16 |
Incyte Pharmaceuticals, Inc. |
Database for storage and analysis of full-length sequences
|
US6114114A
(en)
*
|
1992-07-17 |
2000-09-05 |
Incyte Pharmaceuticals, Inc. |
Comparative gene transcript analysis
|
US5565324A
(en)
*
|
1992-10-01 |
1996-10-15 |
The Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
US5721099A
(en)
*
|
1992-10-01 |
1998-02-24 |
Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
US6503759B1
(en)
|
1992-10-01 |
2003-01-07 |
The Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
IT1270939B
(it)
|
1993-05-11 |
1997-05-26 |
Angeletti P Ist Richerche Bio |
Procedimento per la preparazione di immunogeni e reagenti diagnostici,e immunogeni e reagenti diagnostici cosi' ottenibili.
|
US5432155A
(en)
*
|
1993-06-29 |
1995-07-11 |
The Salk Institute For Biological Studies |
Conotoxins I
|
US5514774A
(en)
*
|
1993-06-29 |
1996-05-07 |
University Of Utah Research Foundation |
Conotoxin peptides
|
US6194544B1
(en)
|
1993-07-09 |
2001-02-27 |
Smithkline Beecham Corporation |
Cyclic semi-random peptide libraries
|
CN1525171A
(zh)
*
|
1993-10-01 |
2004-09-01 |
ŦԼ�и��ױ��Ǵ�ѧ���� |
用标示物编码的多元组合化学库
|
US5879656A
(en)
*
|
1993-10-26 |
1999-03-09 |
Thomas Jefferson University |
Methods of treating metastatic colorectal cancer with ST receptor binding compounds
|
US7097839B1
(en)
*
|
1993-10-26 |
2006-08-29 |
Thomas Jefferson University |
ST receptor binding compounds and methods of using the same
|
US5922545A
(en)
*
|
1993-10-29 |
1999-07-13 |
Affymax Technologies N.V. |
In vitro peptide and antibody display libraries
|
US5492807A
(en)
*
|
1993-11-19 |
1996-02-20 |
Santi; Daniel V. |
Method of obtaining diagnostic reagents, assays and therapeutics based on clinical manifestations of a disease
|
WO1995019567A1
(en)
*
|
1994-01-13 |
1995-07-20 |
The Trustees Of Columbia University In The City Of New York |
Synthetic receptors, libraries and uses thereof
|
US6140466A
(en)
|
1994-01-18 |
2000-10-31 |
The Scripps Research Institute |
Zinc finger protein derivatives and methods therefor
|
US20050084885A1
(en)
*
|
1994-01-18 |
2005-04-21 |
The Scripps Research Institute |
Zinc finger protein derivatives and methods therefor
|
US6165793A
(en)
*
|
1996-03-25 |
2000-12-26 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
US6936477B2
(en)
*
|
1994-04-13 |
2005-08-30 |
The Trustees Of Columbia University In The City Of New York |
Complex combinatorial chemical libraries encoded with tags
|
US5856083A
(en)
*
|
1994-05-06 |
1999-01-05 |
Pharmacopeia, Inc. |
Lawn assay for compounds that affect enzyme activity or bind to target molecules
|
US5525735A
(en)
*
|
1994-06-22 |
1996-06-11 |
Affymax Technologies Nv |
Methods for synthesizing diverse collections of pyrrolidine compounds
|
US5525734A
(en)
*
|
1994-06-22 |
1996-06-11 |
Affymax Technologies N.V. |
Methods for synthesizing diverse collections of pyrrolidine compounds
|
JPH10502534A
(ja)
*
|
1994-07-12 |
1998-03-10 |
ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド |
結合組織増殖因子−2
|
US6010861A
(en)
*
|
1994-08-03 |
2000-01-04 |
Dgi Biotechnologies, Llc |
Target specific screens and their use for discovering small organic molecular pharmacophores
|
AU3330895A
(en)
*
|
1994-08-18 |
1996-03-14 |
Cytogen Corporation |
Peptide librairies as a source of syngenes
|
EP2022856B1
(de)
|
1994-08-20 |
2011-09-14 |
Gendaq Limited |
Verbesserungen bei oder im Zusammenhang mit Bindeproteinen zur Erkennung von DNA
|
GB9824544D0
(en)
|
1998-11-09 |
1999-01-06 |
Medical Res Council |
Screening system
|
US5712096A
(en)
*
|
1994-08-23 |
1998-01-27 |
University Of Massachusetts Medical Center |
Oligoribonucleotide assays for novel antibiotics
|
US5856090A
(en)
*
|
1994-09-09 |
1999-01-05 |
The Scripps Research Institute |
DNA-methylase linking reaction
|
US5463564A
(en)
|
1994-09-16 |
1995-10-31 |
3-Dimensional Pharmaceuticals, Inc. |
System and method of automatically generating chemical compounds with desired properties
|
CA2200684A1
(en)
*
|
1994-09-21 |
1996-03-28 |
Cytogen Corporation |
Antigen binding peptides (abtides) from peptide libraries
|
US5885577A
(en)
*
|
1994-09-21 |
1999-03-23 |
Cytogen Corporation |
Antigen binding peptides (abtides) from peptide libraries
|
US6015668A
(en)
*
|
1994-09-30 |
2000-01-18 |
Life Technologies, Inc. |
Cloned DNA polymerases from thermotoga and mutants thereof
|
US5603351A
(en)
|
1995-06-07 |
1997-02-18 |
David Sarnoff Research Center, Inc. |
Method and system for inhibiting cross-contamination in fluids of combinatorial chemistry device
|
US5585069A
(en)
*
|
1994-11-10 |
1996-12-17 |
David Sarnoff Research Center, Inc. |
Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis
|
CA2204912C
(en)
*
|
1994-11-10 |
2005-01-04 |
David Sarnoff Research Center, Inc. |
Liquid distribution system
|
US6341256B1
(en)
|
1995-03-31 |
2002-01-22 |
Curagen Corporation |
Consensus configurational bias Monte Carlo method and system for pharmacophore structure determination
|
US6309820B1
(en)
*
|
1995-04-07 |
2001-10-30 |
University Of North Carolina At Chapel Hill |
Polypeptides having a functional domain of interest and methods of identifying and using same
|
US5961923A
(en)
*
|
1995-04-25 |
1999-10-05 |
Irori |
Matrices with memories and uses thereof
|
US6025129A
(en)
*
|
1995-04-25 |
2000-02-15 |
Irori |
Remotely programmable matrices with memories and uses thereof
|
US6331273B1
(en)
|
1995-04-25 |
2001-12-18 |
Discovery Partners International |
Remotely programmable matrices with memories
|
US5925562A
(en)
*
|
1995-04-25 |
1999-07-20 |
Irori |
Remotely programmable matrices with memories
|
US6416714B1
(en)
|
1995-04-25 |
2002-07-09 |
Discovery Partners International, Inc. |
Remotely programmable matrices with memories
|
US6100026A
(en)
*
|
1995-04-25 |
2000-08-08 |
Irori |
Matrices with memories and uses thereof
|
US6329139B1
(en)
|
1995-04-25 |
2001-12-11 |
Discovery Partners International |
Automated sorting system for matrices with memory
|
US6284459B1
(en)
|
1995-04-25 |
2001-09-04 |
Discovery Partners International |
Solid support matrices with memories and combinatorial libraries therefrom
|
US6017496A
(en)
|
1995-06-07 |
2000-01-25 |
Irori |
Matrices with memories and uses thereof
|
US5751629A
(en)
|
1995-04-25 |
1998-05-12 |
Irori |
Remotely programmable matrices with memories
|
US5741462A
(en)
*
|
1995-04-25 |
1998-04-21 |
Irori |
Remotely programmable matrices with memories
|
US5874214A
(en)
|
1995-04-25 |
1999-02-23 |
Irori |
Remotely programmable matrices with memories
|
US5834184A
(en)
*
|
1995-05-17 |
1998-11-10 |
Harada; Kazuo |
In vivo selection of RNA-binding peptides
|
US5747453A
(en)
|
1995-06-06 |
1998-05-05 |
Alza Corporation |
Method for increasing the electrotransport flux of polypeptides
|
US5874562A
(en)
*
|
1995-06-07 |
1999-02-23 |
Progenitor, Inc. |
Nucleic acid encoding developmentally-regulated endothelial cell locus-1
|
US5668110A
(en)
*
|
1995-06-07 |
1997-09-16 |
Affymax Technologies N.V. |
Peptides and compounds that bind to the IL-5 receptor
|
US5677280A
(en)
*
|
1995-06-07 |
1997-10-14 |
Glaxo Group Limited |
Peptides and compounds that bind to the IL-5 receptor
|
DK0885242T3
(da)
|
1995-06-07 |
2008-07-14 |
Glaxo Group Ltd |
Peptider og forbindelser, der binder til en trombopoietinreceptor
|
US7041801B1
(en)
|
1995-06-07 |
2006-05-09 |
Vanderbilt University |
Antibodies binding to polypeptides encoded by developmentally-regulated endothelial cell locus-1
|
US5654276A
(en)
*
|
1995-06-07 |
1997-08-05 |
Affymax Technologies N.V. |
Peptides and compounds that bind to the IL-5 receptor
|
US5683983A
(en)
*
|
1995-06-07 |
1997-11-04 |
Glaxo Group Limited |
Peptides and compounds that bind to the IL-5 receptor
|
US5869451A
(en)
*
|
1995-06-07 |
1999-02-09 |
Glaxo Group Limited |
Peptides and compounds that bind to a receptor
|
US6251864B1
(en)
|
1995-06-07 |
2001-06-26 |
Glaxo Group Limited |
Peptides and compounds that bind to a receptor
|
EP0835446B1
(de)
*
|
1995-06-26 |
2003-04-09 |
Perseptive Biosystems, Inc. |
Automatisierte, kontinuierliche mehrdimensionale hochgeschwindigkeitsmolekularselektion und -analyse
|
AU7236296A
(en)
*
|
1995-09-08 |
1997-03-27 |
Life Technologies, Inc. |
Cloned dna polymerases from thermotoga and mutants thereof
|
US6300063B1
(en)
|
1995-11-29 |
2001-10-09 |
Affymetrix, Inc. |
Polymorphism detection
|
US6953663B1
(en)
*
|
1995-11-29 |
2005-10-11 |
Affymetrix, Inc. |
Polymorphism detection
|
US6537776B1
(en)
|
1999-06-14 |
2003-03-25 |
Diversa Corporation |
Synthetic ligation reassembly in directed evolution
|
AU1430297A
(en)
*
|
1995-12-18 |
1997-07-14 |
Praecis Pharmaceuticals Incorporated |
Methods for identifying compounds that bind to a target
|
US6126964A
(en)
*
|
1996-01-04 |
2000-10-03 |
Mirus Corporation |
Process of making a compound by forming a polymer from a template drug
|
DK0877752T3
(da)
*
|
1996-01-23 |
2003-09-15 |
Univ Leland Stanford Junior |
Fremgangsmåder til screening af transdominante effektorpeptider og RNA molekyler
|
US6365344B1
(en)
|
1996-01-23 |
2002-04-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for screening for transdominant effector peptides and RNA molecules
|
US6031071A
(en)
*
|
1996-01-24 |
2000-02-29 |
Biophage, Inc. |
Methods of generating novel peptides
|
US6185506B1
(en)
*
|
1996-01-26 |
2001-02-06 |
Tripos, Inc. |
Method for selecting an optimally diverse library of small molecules based on validated molecular structural descriptors
|
EP0892963A1
(de)
*
|
1996-01-26 |
1999-01-27 |
David E. Patterson |
Verfahren zum erstellen und durchsuchen einer virtuellen molekyl-biblothek mit hilfe von molekylarstruktur-deskriptoren
|
US6277583B1
(en)
|
1996-02-07 |
2001-08-21 |
Conjuchem, Inc. |
Affinity labeling libraries and applications thereof
|
US6432635B1
(en)
|
1996-03-21 |
2002-08-13 |
Helsinki University Licensing Ltd. Oy |
Cystatin B mutants
|
US5866341A
(en)
*
|
1996-04-03 |
1999-02-02 |
Chugai Pharmaceutical Co., Ltd. |
Compositions and methods for screening drug libraries
|
US6190856B1
(en)
*
|
1996-05-22 |
2001-02-20 |
The Johns Hopkins University |
Methods of detection utilizing modified bacteriophage
|
WO1997045538A1
(en)
*
|
1996-05-31 |
1997-12-04 |
Medigene Ag |
Novel synthetic protein structural templates for the generation, screening and evolution of functional molecular surfaces
|
US6333189B1
(en)
|
1996-06-06 |
2001-12-25 |
Alza Corporation |
Method of making an electrotransport device
|
US7091311B2
(en)
*
|
1996-06-07 |
2006-08-15 |
Smithkline Beecham Corporation |
Peptides and compounds that bind to a receptor
|
US6083693A
(en)
|
1996-06-14 |
2000-07-04 |
Curagen Corporation |
Identification and comparison of protein-protein interactions that occur in populations
|
SE9603466D0
(sv)
*
|
1996-09-23 |
1996-09-23 |
Astra Ab |
New compounds
|
DE69718054T2
(de)
*
|
1996-10-04 |
2003-07-17 |
Univ Heidelberg |
Verfahren zur aufreinigung von dns
|
US5932546A
(en)
*
|
1996-10-04 |
1999-08-03 |
Glaxo Wellcome Inc. |
Peptides and compounds that bind to the thrombopoietin receptor
|
US20020022227A1
(en)
*
|
1996-10-17 |
2002-02-21 |
Short Jay M. |
Morphatides: novel shape and structure libraries
|
US6838238B1
(en)
*
|
1996-10-17 |
2005-01-04 |
Invitrogen Corporation |
Morphatides: novel shape and structure libraries
|
US6571227B1
(en)
*
|
1996-11-04 |
2003-05-27 |
3-Dimensional Pharmaceuticals, Inc. |
Method, system and computer program product for non-linear mapping of multi-dimensional data
|
US6453246B1
(en)
|
1996-11-04 |
2002-09-17 |
3-Dimensional Pharmaceuticals, Inc. |
System, method, and computer program product for representing proximity data in a multi-dimensional space
|
CA2270527A1
(en)
*
|
1996-11-04 |
1998-05-14 |
3-Dimensional Pharmaceuticals, Inc. |
System, method, and computer program product for the visualization and interactive processing and analysis of chemical data
|
US5942422A
(en)
*
|
1996-11-14 |
1999-08-24 |
The Trustees Of Columbia University In The City Of New York |
Method for generating a directed, recombinant fusion nucleic acid
|
US6261804B1
(en)
*
|
1997-01-21 |
2001-07-17 |
The General Hospital Corporation |
Selection of proteins using RNA-protein fusions
|
WO1998031700A1
(en)
|
1997-01-21 |
1998-07-23 |
The General Hospital Corporation |
Selection of proteins using rna-protein fusions
|
US8207093B2
(en)
*
|
1997-01-21 |
2012-06-26 |
The General Hospital Corporation |
Selection of proteins using RNA-protein fusions
|
US6087115A
(en)
*
|
1997-01-22 |
2000-07-11 |
Cornell Research Foundation, Inc. |
Methods of identifying negative antagonists for G protein coupled receptors
|
US6403305B1
(en)
|
1997-02-06 |
2002-06-11 |
Cornell Research Foundation, Inc. |
Methods of identifying peptide agonists or negative antagonists of a G protein coupled receptor
|
US6306588B1
(en)
*
|
1997-02-07 |
2001-10-23 |
Invitrogen Corporation |
Polymerases for analyzing or typing polymorphic nucleic acid fragments and uses thereof
|
GB2338237B
(en)
*
|
1997-02-18 |
2001-02-28 |
Actinova Ltd |
In vitro peptide or protein expression library
|
GB9703369D0
(en)
*
|
1997-02-18 |
1997-04-09 |
Lindqvist Bjorn H |
Process
|
US6187536B1
(en)
|
1997-02-18 |
2001-02-13 |
Thomas Jefferson University |
Methods of identifying and detecting pancreatic cancer
|
US7053177B1
(en)
|
1997-05-15 |
2006-05-30 |
Cytogen Corporation |
Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods
|
US7135457B1
(en)
|
1997-05-15 |
2006-11-14 |
Cytogen Corporation |
Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods
|
US6703362B1
(en)
|
1997-05-15 |
2004-03-09 |
Cytogen Corporation |
Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods
|
WO1998051325A2
(en)
*
|
1997-05-15 |
1998-11-19 |
Cytogen Corporation |
Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
|
GB9710809D0
(en)
|
1997-05-23 |
1997-07-23 |
Medical Res Council |
Nucleic acid binding proteins
|
US6368877B1
(en)
*
|
1997-06-25 |
2002-04-09 |
Massachusetts Institute Of Technology |
Self-assembling peptide surfaces for cell patterning and interactions
|
DK1019496T3
(da)
*
|
1997-07-07 |
2005-01-10 |
Medical Res Council |
In vitro-sorteringsmetode
|
FR2767135B1
(fr)
*
|
1997-08-06 |
2002-07-12 |
Genset Sa |
Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
|
US6120995A
(en)
*
|
1997-08-07 |
2000-09-19 |
Thomas Jefferson University |
Compositions that specifically bind to colorectal cancer cells and methods of using the same
|
US7135333B1
(en)
|
1997-08-07 |
2006-11-14 |
Thomas Jefferson University |
Compositions that specifically bind to colorectal cancer cells and methods of using the same
|
GB9718455D0
(en)
*
|
1997-09-02 |
1997-11-05 |
Mcgregor Duncan P |
Chimeric binding peptide library screening method
|
US6607878B2
(en)
|
1997-10-06 |
2003-08-19 |
Stratagene |
Collections of uniquely tagged molecules
|
ATE406577T1
(de)
|
1997-11-07 |
2008-09-15 |
Conjuchem Biotechnologies Inc |
Methoden zum screening von affinitätsmarker- bibliotheken
|
US20020064792A1
(en)
*
|
1997-11-13 |
2002-05-30 |
Lincoln Stephen E. |
Database for storage and analysis of full-length sequences
|
US6759243B2
(en)
|
1998-01-20 |
2004-07-06 |
Board Of Trustees Of The University Of Illinois |
High affinity TCR proteins and methods
|
US6410248B1
(en)
|
1998-01-30 |
2002-06-25 |
Massachusetts Institute Of Technology |
General strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites
|
US6541011B2
(en)
|
1998-02-11 |
2003-04-01 |
Maxygen, Inc. |
Antigen library immunization
|
US7390619B1
(en)
*
|
1998-02-11 |
2008-06-24 |
Maxygen, Inc. |
Optimization of immunomodulatory properties of genetic vaccines
|
EP1060261B1
(de)
*
|
1998-03-02 |
2010-05-05 |
Massachusetts Institute of Technology |
Poly-zinkfinger-proteine mit verbesserten linkern
|
US6977154B1
(en)
|
1998-03-17 |
2005-12-20 |
Gendaq Limited |
Nucleic acid binding proteins
|
AU3363399A
(en)
*
|
1998-03-27 |
1999-10-18 |
President And Fellows Of Harvard College |
Aptamer based bacterial inhibition systems (abbis)
|
US7153655B2
(en)
|
1998-06-16 |
2006-12-26 |
Alligator Bioscience Ab |
Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequence
|
AU5122499A
(en)
|
1998-07-27 |
2000-02-21 |
Genentech Inc. |
Improved transformation efficiency in phage display through modification of a coat protein
|
DE69941193D1
(de)
|
1998-08-17 |
2009-09-10 |
Bristol Myers Squibb Co |
Identifizierung von verbindung-protein wechselwirkungen mit bibliotheken von gekoppelten protein-nukleinsäure-molekülen
|
US20070178475A1
(en)
*
|
1998-09-17 |
2007-08-02 |
Nehls Michael C |
Novel human polynucleotides and polypeptides encoded thereby
|
DE19845420C2
(de)
*
|
1998-10-02 |
2000-11-16 |
Deutsches Krebsforsch |
Interzelluläre Ausbreitung rekombinanter DNA
|
US7488590B2
(en)
*
|
1998-10-23 |
2009-02-10 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
CN1810832B
(zh)
|
1998-10-23 |
2012-12-12 |
麒麟-安姆根有限公司 |
与MPl受体结合并具有血小板生成活性的模拟二聚体血小板生成素肽
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
WO2000026363A1
(en)
*
|
1998-11-04 |
2000-05-11 |
Genset |
GENOMIC AND COMPLETE cDNA SEQUENCES OF HUMAN ADIPOCYTE-SPECIFIC APM1 AND BIALLELIC MARKERS THEREOF
|
WO2000028018A1
(en)
|
1998-11-10 |
2000-05-18 |
Maxygen, Inc. |
Modified adp-glucose pyrophosphorylase for improvement and optimization of plant phenotypes
|
WO2000032823A1
(en)
|
1998-12-02 |
2000-06-08 |
Phylos, Inc. |
Dna-protein fusions and uses thereof
|
AU2004242526B2
(en)
*
|
1999-01-07 |
2007-08-30 |
United Kingdom Research And Innovation |
Optical Sorting Method
|
GB9900298D0
(en)
*
|
1999-01-07 |
1999-02-24 |
Medical Res Council |
Optical sorting method
|
US6599692B1
(en)
|
1999-09-14 |
2003-07-29 |
Sangamo Bioscience, Inc. |
Functional genomics using zinc finger proteins
|
US6534261B1
(en)
|
1999-01-12 |
2003-03-18 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
US7070934B2
(en)
|
1999-01-12 |
2006-07-04 |
Sangamo Biosciences, Inc. |
Ligand-controlled regulation of endogenous gene expression
|
US6453242B1
(en)
*
|
1999-01-12 |
2002-09-17 |
Sangamo Biosciences, Inc. |
Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
|
US7013219B2
(en)
*
|
1999-01-12 |
2006-03-14 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
DE60041912D1
(de)
|
1999-02-10 |
2009-05-14 |
Serono Genetics Inst Sa |
Polymorphe marker des lsr-gens
|
US6794136B1
(en)
|
2000-11-20 |
2004-09-21 |
Sangamo Biosciences, Inc. |
Iterative optimization in the design of binding proteins
|
US20030104526A1
(en)
*
|
1999-03-24 |
2003-06-05 |
Qiang Liu |
Position dependent recognition of GNN nucleotide triplets by zinc fingers
|
US7030215B2
(en)
*
|
1999-03-24 |
2006-04-18 |
Sangamo Biosciences, Inc. |
Position dependent recognition of GNN nucleotide triplets by zinc fingers
|
US20020110809A1
(en)
*
|
1999-04-30 |
2002-08-15 |
Nehls Michael C. |
Novel human polynucleotides and polypeptides encoded thereby
|
US20020095031A1
(en)
*
|
1999-05-04 |
2002-07-18 |
Nehls Michael C. |
Novel human polynucleotides and polypeptides encoded thereby
|
US6485690B1
(en)
|
1999-05-27 |
2002-11-26 |
Orchid Biosciences, Inc. |
Multiple fluid sample processor and system
|
US6653151B2
(en)
|
1999-07-30 |
2003-11-25 |
Large Scale Proteomics Corporation |
Dry deposition of materials for microarrays using matrix displacement
|
US7179638B2
(en)
|
1999-07-30 |
2007-02-20 |
Large Scale Biology Corporation |
Microarrays and their manufacture by slicing
|
US6713309B1
(en)
|
1999-07-30 |
2004-03-30 |
Large Scale Proteomics Corporation |
Microarrays and their manufacture
|
US20110104675A1
(en)
*
|
1999-08-09 |
2011-05-05 |
Pacific Northwest Research Institute |
Methods and Compositions for Diagnosing Carcinomas
|
AU781478B2
(en)
*
|
1999-08-20 |
2005-05-26 |
Johns Hopkins University School Of Medicine, The |
Methods and compositions for the construction and use of fusion libraries
|
AU7473500A
(en)
|
1999-09-01 |
2001-03-26 |
University Of Pittsburgh |
Identification of peptides that facilitate uptake and cytoplasmic and/or nucleartransport of proteins, dna and viruses
|
US20030219826A1
(en)
*
|
1999-09-01 |
2003-11-27 |
Robbins Paul D. |
Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
|
US20030104622A1
(en)
*
|
1999-09-01 |
2003-06-05 |
Robbins Paul D. |
Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
|
US6432409B1
(en)
*
|
1999-09-14 |
2002-08-13 |
Antigen Express, Inc. |
Hybrid peptides modulate the immune response
|
US9289487B2
(en)
*
|
1999-09-14 |
2016-03-22 |
Antigen Express, Inc. |
II-key/antigenic epitope hybrid peptide vaccines
|
US20030235594A1
(en)
*
|
1999-09-14 |
2003-12-25 |
Antigen Express, Inc. |
Ii-Key/antigenic epitope hybrid peptide vaccines
|
US20040002474A1
(en)
*
|
1999-10-07 |
2004-01-01 |
Maxygen Inc. |
IFN-alpha homologues
|
US7332275B2
(en)
|
1999-10-13 |
2008-02-19 |
Sequenom, Inc. |
Methods for detecting methylated nucleotides
|
RU2002113076A
(ru)
|
1999-11-18 |
2004-03-10 |
Корвас Интернэшнл, Инк. (Us) |
Кодирующие эндотелиазы нуклеиновые кислоты, эндотелиазы и их использование
|
US6703480B1
(en)
|
1999-11-24 |
2004-03-09 |
Palani Balu |
Peptide dimers as agonists of the erythropoientin (EPO) receptor, and associated methods of synthesis and use
|
WO2001040798A2
(en)
|
1999-12-06 |
2001-06-07 |
Sangamo Biosciences, Inc. |
Methods of using randomized libraries of zinc finger proteins for the identification of gene function
|
AU784983B2
(en)
*
|
1999-12-15 |
2006-08-17 |
Genentech Inc. |
Shotgun scanning, a combinatorial method for mapping functional protein epitopes
|
US8642284B1
(en)
|
1999-12-15 |
2014-02-04 |
Massachusetts Institute Of Technology |
Methods for identifying agents that alter NAD-dependent deacetylation activity of a SIR2 protein
|
US7452664B2
(en)
*
|
1999-12-15 |
2008-11-18 |
Massachusetts Institute Of Technology |
Methods for identifying agents which alter histone protein acetylation
|
US7109299B1
(en)
|
1999-12-16 |
2006-09-19 |
Affymax, Inc. |
Peptides and compounds that bind to the IL-5 receptor
|
US7338787B2
(en)
*
|
2000-01-14 |
2008-03-04 |
Serono Genetics Institute S.A. |
Nucleic acids encoding OBG3 globular head and uses thereof
|
US6566332B2
(en)
|
2000-01-14 |
2003-05-20 |
Genset S.A. |
OBG3 globular head and uses thereof for decreasing body mass
|
US20020058617A1
(en)
*
|
2000-01-14 |
2002-05-16 |
Joachim Fruebis |
OBG3 globular head and uses thereof for decreasing body mass
|
US6989367B2
(en)
*
|
2000-01-14 |
2006-01-24 |
Genset S.A. |
OBG3 globular head and uses thereof
|
WO2001053480A1
(en)
*
|
2000-01-24 |
2001-07-26 |
Sangamo Biosciences, Inc. |
Nucleic acid binding polypeptides characterized by flexible linkers connected nucleic acid binding modules
|
US7022479B2
(en)
*
|
2000-01-24 |
2006-04-04 |
Compound Therapeutics, Inc. |
Sensitive, multiplexed diagnostic assays for protein analysis
|
WO2001053539A1
(en)
|
2000-01-24 |
2001-07-26 |
Phylos, Inc. |
Sensitive, multiplexed diagnostic assays for protein analysis
|
US6489466B2
(en)
|
2000-01-28 |
2002-12-03 |
Linden Technologies, Inc. |
C-3′ protected monomeric nucleotides and synthesis of oligonucleotides on solid support
|
US7700341B2
(en)
|
2000-02-03 |
2010-04-20 |
Dendreon Corporation |
Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
|
EP1254212A2
(de)
|
2000-02-09 |
2002-11-06 |
Genvec, Inc. |
Verfahren zur herstellung und verwendung von einer bibliothek von viralen vektoren
|
US7416524B1
(en)
|
2000-02-18 |
2008-08-26 |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
System, method and computer program product for fast and efficient searching of large chemical libraries
|
WO2001062981A1
(en)
*
|
2000-02-25 |
2001-08-30 |
Montclair Group |
Platform for the discovery of the bacterial genes involved in rna modification
|
AU2001241800A1
(en)
|
2000-02-29 |
2001-09-12 |
3-Dimensional Pharmaceuticals, Inc. |
Method and computer program product for designing combinatorial arrays
|
US7039621B2
(en)
|
2000-03-22 |
2006-05-02 |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
System, method, and computer program product for representing object relationships in a multidimensional space
|
DE60140865D1
(de)
*
|
2000-03-27 |
2010-02-04 |
Univ Jefferson |
Zusammensetzungen und methoden zur identifizierung von krebszellen
|
WO2001075790A2
(en)
|
2000-04-03 |
2001-10-11 |
3-Dimensional Pharmaceuticals, Inc. |
Method, system, and computer program product for representing object relationships in a multidimensional space
|
ES2528794T3
(es)
|
2000-04-11 |
2015-02-12 |
Genentech, Inc. |
Anticuerpos multivalentes y usos de los mismos
|
DE60141088D1
(de)
*
|
2000-04-14 |
2010-03-04 |
Genencor Int |
Verfahren zur selektiven zielen
|
CA2407083A1
(en)
|
2000-04-21 |
2001-11-01 |
Amgen Inc. |
Apo-ai/aii peptide derivatives
|
US6248541B1
(en)
|
2000-04-21 |
2001-06-19 |
Genencor International, Inc. |
Screening under nutrient limited conditions
|
CA2407956A1
(en)
*
|
2000-05-03 |
2001-11-08 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
US6677136B2
(en)
|
2000-05-03 |
2004-01-13 |
Amgen Inc. |
Glucagon antagonists
|
US6534292B1
(en)
*
|
2000-05-08 |
2003-03-18 |
Genencor International, Inc. |
Methods for forming recombined nucleic acids
|
US20020110843A1
(en)
*
|
2000-05-12 |
2002-08-15 |
Dumas David P. |
Compositions and methods for epitope mapping
|
WO2001092549A2
(en)
*
|
2000-05-31 |
2001-12-06 |
Genvec, Inc. |
Method and composition for targeting an adenoviral vector
|
US20040168209A1
(en)
*
|
2000-06-12 |
2004-08-26 |
Alejandro Abuin |
Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby
|
ATE415978T1
(de)
|
2000-07-27 |
2008-12-15 |
Genentech Inc |
Sequentielle verabreichung von cpt-11 und apo-2l polypeptid
|
US7288390B2
(en)
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
US7198924B2
(en)
|
2000-12-11 |
2007-04-03 |
Invitrogen Corporation |
Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
|
JP2004507821A
(ja)
*
|
2000-08-22 |
2004-03-11 |
3−ディメンショナル ファーマシューティカルズ, インコーポレイテッド |
ライブラリー構築ブロックの特徴からのコンビナトリアルライブラリー生成物の特性を決定するための方法、システムおよびコンピュータプログラム製品
|
US6980674B2
(en)
*
|
2000-09-01 |
2005-12-27 |
Large Scale Proteomics Corp. |
Reference database
|
US6539102B1
(en)
|
2000-09-01 |
2003-03-25 |
Large Scale Proteomics |
Reference database
|
EP1332209B1
(de)
|
2000-09-08 |
2009-11-11 |
Universität Zürich |
Sammlung von proteinen mit sich wiederholenden sequenzen (repeat proteins), die repetitive sequenzmodule enthalten
|
WO2002022885A1
(en)
*
|
2000-09-18 |
2002-03-21 |
Thomas Jefferson University |
Compositions and methods for identifying and targeting stomach and esophageal cancer cells
|
US6678619B2
(en)
*
|
2000-09-20 |
2004-01-13 |
Victor S. Lobanov |
Method, system, and computer program product for encoding and building products of a virtual combinatorial library
|
US6582914B1
(en)
|
2000-10-26 |
2003-06-24 |
Genencor International, Inc. |
Method for generating a library of oligonucleotides comprising a controlled distribution of mutations
|
US20020155439A1
(en)
*
|
2000-12-04 |
2002-10-24 |
Ana Rodriguez |
Method for generating a library of mutant oligonucleotides using the linear cyclic amplification reaction
|
US7067317B2
(en)
*
|
2000-12-07 |
2006-06-27 |
Sangamo Biosciences, Inc. |
Regulation of angiogenesis with zinc finger proteins
|
JP2004537260A
(ja)
*
|
2000-12-07 |
2004-12-16 |
サンガモ バイオサイエンシーズ, インコーポレイテッド |
ジンクフィンガータンパク質による血管新生の調節
|
WO2002059310A2
(en)
|
2000-12-12 |
2002-08-01 |
University Of Connecticut |
Polynucleotides encoding cellular transporters and methods of use thereof
|
US20030082647A1
(en)
*
|
2000-12-12 |
2003-05-01 |
Reenan Robert A. |
Transporter protein
|
US6958213B2
(en)
|
2000-12-12 |
2005-10-25 |
Alligator Bioscience Ab |
Method for in vitro molecular evolution of protein function
|
US7572575B2
(en)
|
2000-12-13 |
2009-08-11 |
Massachusetts Institute Of Technology |
SIR2 activity
|
WO2002066653A2
(en)
*
|
2000-12-14 |
2002-08-29 |
Xencor |
Procaryotic libraries and uses
|
US6933109B2
(en)
*
|
2000-12-22 |
2005-08-23 |
Large Scale Proteomics Corporation |
Rapid particle detection
|
US20020086292A1
(en)
|
2000-12-22 |
2002-07-04 |
Shigeaki Harayama |
Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules
|
US20030009293A1
(en)
*
|
2001-01-09 |
2003-01-09 |
Anderson Norman G. |
Reference database
|
CA2435394C
(en)
*
|
2001-01-22 |
2018-01-09 |
Sangamo Biosciences, Inc. |
Modified zinc finger binding proteins
|
US7054757B2
(en)
*
|
2001-01-29 |
2006-05-30 |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
Method, system, and computer program product for analyzing combinatorial libraries
|
WO2002068453A2
(en)
*
|
2001-02-22 |
2002-09-06 |
Xencor |
Methods and compositions for the construction and use of fusion libraries using computational protein design methods
|
US20020168640A1
(en)
*
|
2001-02-22 |
2002-11-14 |
Min Li |
Biochips comprising nucleic acid/protein conjugates
|
WO2002072786A2
(en)
|
2001-03-13 |
2002-09-19 |
Corvas International, Inc. |
Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon
|
WO2002074929A2
(en)
*
|
2001-03-19 |
2002-09-26 |
President And Fellows Of Harvard College |
Evolving new molecular function
|
US7172892B2
(en)
|
2001-03-22 |
2007-02-06 |
Dendreon Corporation |
Nucleic acid molecules encoding serine protease CVSP14, the encoded polypeptides and methods based thereon
|
WO2002077267A2
(en)
|
2001-03-27 |
2002-10-03 |
Dendreon San Diego Llc |
Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon
|
US7309783B2
(en)
*
|
2001-05-09 |
2007-12-18 |
The University Of Connecticut |
Mammalian early developmental regulator gene
|
ES2527471T3
(es)
|
2001-05-11 |
2015-01-26 |
Amgen Inc. |
Péptidos y moléculas relacionadas que se unen a TALL-1
|
CA2447050A1
(en)
|
2001-05-14 |
2002-11-21 |
Dendreon San Diego Llc |
Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
|
US20030148380A1
(en)
*
|
2001-06-05 |
2003-08-07 |
Belcher Angela M. |
Molecular recognition of materials
|
US20050164515A9
(en)
*
|
2001-06-05 |
2005-07-28 |
Belcher Angela M. |
Biological control of nanoparticle nucleation, shape and crystal phase
|
US20030113714A1
(en)
*
|
2001-09-28 |
2003-06-19 |
Belcher Angela M. |
Biological control of nanoparticles
|
US20070160576A1
(en)
|
2001-06-05 |
2007-07-12 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
EP1992643A3
(de)
|
2001-06-20 |
2008-12-10 |
Genentech, Inc. |
Zusammensetzungen und Verfahren zur Behandlung und Diagnose von Tumoren
|
US20050107595A1
(en)
*
|
2001-06-20 |
2005-05-19 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
US7803915B2
(en)
*
|
2001-06-20 |
2010-09-28 |
Genentech, Inc. |
Antibody compositions for the diagnosis and treatment of tumor
|
ATE371026T1
(de)
|
2001-06-20 |
2007-09-15 |
Nuevolution As |
Eine methode zur synthese von matrizenabhängigen molekülen
|
US20030007973A1
(en)
*
|
2001-06-22 |
2003-01-09 |
Lynes Michael A. |
Methods and compositions for manipulation of the immune response using anti-metallothionein antibody
|
JP2004533840A
(ja)
*
|
2001-07-06 |
2004-11-11 |
ジェネンテック・インコーポレーテッド |
ファージディスプレイによるpdzドメインリガンド
|
AU2002355955A1
(en)
*
|
2001-08-13 |
2003-03-03 |
University Of Southern California |
Interleukin-2 mutants with reduced toxicity
|
WO2003024392A2
(en)
|
2001-09-18 |
2003-03-27 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
US20030073104A1
(en)
*
|
2001-10-02 |
2003-04-17 |
Belcher Angela M. |
Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus
|
US7138370B2
(en)
|
2001-10-11 |
2006-11-21 |
Amgen Inc. |
Specific binding agents of human angiopoietin-2
|
US7332474B2
(en)
*
|
2001-10-11 |
2008-02-19 |
Amgen Inc. |
Peptides and related compounds having thrombopoietic activity
|
WO2003088808A2
(en)
|
2002-04-16 |
2003-10-30 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
GB0127564D0
(en)
|
2001-11-16 |
2002-01-09 |
Medical Res Council |
Emulsion compositions
|
AU2002357004A1
(en)
*
|
2001-11-20 |
2003-06-10 |
Dendreon San Diego Llc |
Nucleic acid molecules encoding serine protease 17, the encoded polypeptides and methods based thereon
|
AU2002350332A1
(en)
*
|
2001-12-17 |
2003-06-30 |
Tao Chen |
Methods of parallel gene cloning and analysis
|
EP1575571A4
(de)
|
2002-01-02 |
2008-06-25 |
Genentech Inc |
Zusammensetzungen und verfahren zur diagnose und behandlung eines tumors
|
US7262054B2
(en)
*
|
2002-01-22 |
2007-08-28 |
Sangamo Biosciences, Inc. |
Zinc finger proteins for DNA binding and gene regulation in plants
|
WO2009095742A1
(en)
|
2008-01-31 |
2009-08-06 |
Cellectis |
New i-crei derived single-chain meganuclease and uses thereof
|
NZ535602A
(en)
|
2002-04-08 |
2006-07-28 |
Pioneer Hi Bred Int |
Enhanced silk exsertion under stress in Zea mays plants
|
WO2003093296A2
(en)
|
2002-05-03 |
2003-11-13 |
Sequenom, Inc. |
Kinase anchor protein muteins, peptides thereof, and related methods
|
CA2485506C
(en)
|
2002-05-17 |
2012-02-28 |
Alligator Bioscience Ab |
A method for in vitro molecular evolution of protein function
|
US20040001801A1
(en)
*
|
2002-05-23 |
2004-01-01 |
Corvas International, Inc. |
Conjugates activated by cell surface proteases and therapeutic uses thereof
|
EP1513879B1
(de)
*
|
2002-06-03 |
2018-08-22 |
Genentech, Inc. |
Bibliotheken synthetischer antikörperphagen
|
EP2305710A3
(de)
|
2002-06-03 |
2013-05-29 |
Genentech, Inc. |
Synthetische Antikörperphagenbibliotheken
|
US9321832B2
(en)
|
2002-06-28 |
2016-04-26 |
Domantis Limited |
Ligand
|
JP4657919B2
(ja)
*
|
2002-08-19 |
2011-03-23 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
進化する新しい分子機能
|
US7361635B2
(en)
*
|
2002-08-29 |
2008-04-22 |
Sangamo Biosciences, Inc. |
Simultaneous modulation of multiple genes
|
US7179645B2
(en)
*
|
2002-09-24 |
2007-02-20 |
Antigen Express, Inc. |
Ii-Key/antigenic epitope hybrid peptide vaccines
|
AU2003294220A1
(en)
|
2002-09-17 |
2004-04-23 |
Antigen Express, Inc. |
Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES
|
US20050064508A1
(en)
|
2003-09-22 |
2005-03-24 |
Semzyme |
Peptide mediated synthesis of metallic and magnetic materials
|
CA2499625A1
(en)
|
2002-09-18 |
2004-04-01 |
Ortho-Mcneil Pharmaceutical, Inc. |
Methods of increasing platelet and hematopoietic stem cell production
|
US6919426B2
(en)
|
2002-09-19 |
2005-07-19 |
Amgen Inc. |
Peptides and related molecules that modulate nerve growth factor activity
|
CN1787837A
(zh)
|
2002-11-15 |
2006-06-14 |
希龙公司 |
防止和治疗癌转移以及与癌转移相关的骨质损失的方法
|
US20050147962A1
(en)
*
|
2002-11-19 |
2005-07-07 |
Wagstrom Christopher R. |
Display of dimeric proteins on phage
|
AU2004205631A1
(en)
*
|
2003-01-16 |
2004-08-05 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
US20060206949A1
(en)
|
2003-01-28 |
2006-09-14 |
Sylvain Arnould |
Custom-made meganuclease and use thereof
|
ES2338654T5
(es)
|
2003-01-29 |
2017-12-11 |
454 Life Sciences Corporation |
Amplificación de ácidos nucleicos en emulsión de perlas
|
US8206704B2
(en)
*
|
2003-02-10 |
2012-06-26 |
Thomas Jefferson University |
Use of GCC ligands
|
US10533998B2
(en)
|
2008-07-18 |
2020-01-14 |
Bio-Rad Laboratories, Inc. |
Enzyme quantification
|
US8017323B2
(en)
|
2003-03-26 |
2011-09-13 |
President And Fellows Of Harvard College |
Free reactant use in nucleic acid-templated synthesis
|
GB0307403D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Selection by compartmentalised screening
|
GB0307428D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Compartmentalised combinatorial chemistry
|
US20060078893A1
(en)
|
2004-10-12 |
2006-04-13 |
Medical Research Council |
Compartmentalised combinatorial chemistry by microfluidic control
|
US8613922B2
(en)
|
2003-04-24 |
2013-12-24 |
The University Of North Carolina At Chapel Hill |
Methods for inhibiting diabetic retinopathy with an antibody against integrin associated protein (IAP)
|
US9708410B2
(en)
|
2003-05-30 |
2017-07-18 |
Janssen Biotech, Inc. |
Anti-tissue factor antibodies and compositions
|
KR20060027801A
(ko)
|
2003-06-05 |
2006-03-28 |
제넨테크, 인크. |
B 세포 장애에 대한 조합 요법
|
US20050136429A1
(en)
*
|
2003-07-03 |
2005-06-23 |
Massachusetts Institute Of Technology |
SIRT1 modulation of adipogenesis and adipose function
|
WO2005010145A2
(en)
|
2003-07-05 |
2005-02-03 |
The Johns Hopkins University |
Method and compositions for detection and enumeration of genetic variations
|
SI1641822T1
(sl)
|
2003-07-08 |
2013-08-30 |
Genentech, Inc. |
IL-17 A/F heterologni polipeptidi in njihove terapevtske uporabe
|
US20050106667A1
(en)
|
2003-08-01 |
2005-05-19 |
Genentech, Inc |
Binding polypeptides with restricted diversity sequences
|
US7758859B2
(en)
|
2003-08-01 |
2010-07-20 |
Genentech, Inc. |
Anti-VEGF antibodies
|
US20050048589A1
(en)
*
|
2003-08-25 |
2005-03-03 |
Moncef Jendoubi |
Lung cancer specific gene products: their coding sequence, their antibodies and their use in diagnostic, therapeutic and disease management of lung cancer
|
MXPA06002292A
(es)
*
|
2003-08-28 |
2006-09-04 |
Johnson & Johnson |
Peptidos y compuestos que se unen a un receptor.
|
US7723295B2
(en)
*
|
2003-08-28 |
2010-05-25 |
Ortho-Mcneil Pharmaceutical, Inc. |
Peptides and compounds that bind to a receptor
|
EP1689432B1
(de)
|
2003-11-17 |
2009-12-30 |
Genentech, Inc. |
Zusammensetzungen und verfahren zur behandlung von tumoren hämatopoetischen ursprungs
|
US20050164969A1
(en)
*
|
2003-11-19 |
2005-07-28 |
Massachusetts Institute Of Technology |
Method of extending life span
|
EP2287341B1
(de)
|
2003-12-01 |
2013-02-13 |
Life Technologies Corporation |
Rekombinationsstellen enthaltende Nukleinsäuremoleküle und Verfahren zur Verwendung davon
|
EP2168986A3
(de)
|
2004-02-19 |
2010-07-28 |
Genentech, Inc. |
Antikörper mit korrigiertem CDR
|
US20050221339A1
(en)
|
2004-03-31 |
2005-10-06 |
Medical Research Council Harvard University |
Compartmentalised screening by microfluidic control
|
US7785903B2
(en)
*
|
2004-04-09 |
2010-08-31 |
Genentech, Inc. |
Variable domain library and uses
|
EP1789453A2
(de)
*
|
2004-05-18 |
2007-05-30 |
Genentech, Inc. |
Haupthüllproteinvarianten des m13-virus zur c-terminalen und bi-terminalen anzeige eines heterologen proteins
|
US7323347B2
(en)
*
|
2004-05-27 |
2008-01-29 |
Sensata Technologies, Inc. |
Biosensor surface structures and methods
|
US20060008844A1
(en)
|
2004-06-17 |
2006-01-12 |
Avidia Research Institute |
c-Met kinase binding proteins
|
MX2007000216A
(es)
*
|
2004-07-08 |
2007-03-15 |
Amgen Inc |
Peptidos terapeuticos.
|
US20060014680A1
(en)
*
|
2004-07-13 |
2006-01-19 |
Caiding Xu |
Peptides and compounds that bind to the IL-5 receptor
|
US20060210542A1
(en)
*
|
2004-08-16 |
2006-09-21 |
Yurkow Edward J |
Use of TPO mimetic compounds and pharmaceutical compositions in the treatment of anemia
|
GB0418651D0
(en)
|
2004-08-20 |
2004-09-22 |
Medical Res Council |
Method
|
US20060057105A1
(en)
*
|
2004-08-20 |
2006-03-16 |
Stern Michael E |
Methods of treating ocular inflammation and allergy
|
WO2006021954A2
(en)
|
2004-08-23 |
2006-03-02 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Peptide inhibitors for mediating stress responses
|
RS57636B1
(sr)
|
2004-09-03 |
2018-11-30 |
Genentech Inc |
Humanizovani anti-beta7 antagonisti i njihova upotreba
|
US7442778B2
(en)
|
2004-09-24 |
2008-10-28 |
Amgen Inc. |
Modified Fc molecules
|
US7968287B2
(en)
|
2004-10-08 |
2011-06-28 |
Medical Research Council Harvard University |
In vitro evolution in microfluidic systems
|
WO2006056009A1
(en)
*
|
2004-11-23 |
2006-06-01 |
Hepgenics Pty Ltd |
Peptides having adhesive properties for use in solid phase assay and chemical polymer synthesis regimes.
|
US8022040B2
(en)
*
|
2004-11-29 |
2011-09-20 |
The Regents Of The University Of California |
Hydroxyapatite-binding peptides for bone growth and inhibition
|
ATE425186T1
(de)
|
2005-01-05 |
2009-03-15 |
F Star Biotech Forsch & Entw |
Synthetische immunoglobulindomänen mit in regionen des moleküls, die sich von den die komplementarität bestimmenden bereichen unterscheiden, modifizierten bindeeigenschaften
|
CN101175769A
(zh)
|
2005-03-10 |
2008-05-07 |
健泰科生物技术公司 |
用于调控血管完整性的方法和组合物
|
WO2006099386A2
(en)
*
|
2005-03-11 |
2006-09-21 |
Massachusetts Institute Of Technology |
Synthesis and use of colloidal iii-v nanoparticles
|
US20070099830A1
(en)
|
2005-04-21 |
2007-05-03 |
Massachusetts Institute Of Technology |
Sirt4 activities
|
JO3058B1
(ar)
|
2005-04-29 |
2017-03-15 |
Applied Molecular Evolution Inc |
الاجسام المضادة لمضادات -اي ال-6,تركيباتها طرقها واستعمالاتها
|
PE20061444A1
(es)
|
2005-05-19 |
2007-01-15 |
Centocor Inc |
Anticuerpo anti-mcp-1, composiciones, metodos y usos
|
WO2007094842A2
(en)
*
|
2005-12-02 |
2007-08-23 |
Genentech, Inc. |
Binding polypeptides and uses thereof
|
JP2009501006A
(ja)
|
2005-06-30 |
2009-01-15 |
セントカー・インコーポレーテツド |
抗il−23抗体、組成物、方法および用途
|
WO2007011722A2
(en)
|
2005-07-15 |
2007-01-25 |
President And Fellows Of Harvard College |
Reaction discovery system
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
KR20140077946A
(ko)
|
2005-10-13 |
2014-06-24 |
휴먼 게놈 사이언시즈, 인코포레이티드 |
자가항체 양성 질환 환자의 치료에 유용한 방법 및 조성물
|
ES2577292T3
(es)
|
2005-11-07 |
2016-07-14 |
Genentech, Inc. |
Polipéptidos de unión con secuencias hipervariables de VH/VL diversificadas y consenso
|
UA96139C2
(uk)
|
2005-11-08 |
2011-10-10 |
Дженентек, Інк. |
Антитіло до нейропіліну-1 (nrp1)
|
GB2432366B
(en)
*
|
2005-11-19 |
2007-11-21 |
Alligator Bioscience Ab |
A method for in vitro molecular evolution of protein function
|
HUE034269T2
(en)
|
2005-12-29 |
2018-02-28 |
Janssen Biotech Inc |
Human anti-IL-23 antibodies, preparations, methods and applications
|
WO2007081386A2
(en)
|
2006-01-11 |
2007-07-19 |
Raindance Technologies, Inc. |
Microfluidic devices and methods of use
|
US20070175313A1
(en)
*
|
2006-01-31 |
2007-08-02 |
Kevin Vandervliet |
MP3 player holder assembly
|
WO2007095335A2
(en)
|
2006-02-13 |
2007-08-23 |
Donaldson Company, Inc. |
Filter web comprising fine fiber and reactive, adsorptive or absorptive particulate
|
CA2646391A1
(en)
|
2006-03-22 |
2007-09-27 |
Viral Logic Systems Technology Corp. |
Methods for identifying polypeptide targets and uses thereof for treating immunological diseases
|
US8129334B2
(en)
|
2006-03-31 |
2012-03-06 |
The Regents Of The University Of California |
Methods and compositions for treating neurodegenerative disorders and Alzheimer'S disease and improving normal memory
|
EP2614839A3
(de)
|
2006-04-05 |
2015-01-28 |
Genentech, Inc. |
Verfahren zur Verwendung von BOC/CDO zur Modulation der Hedgehog-Signalisierung
|
JO3324B1
(ar)
|
2006-04-21 |
2019-03-13 |
Amgen Inc |
مركبات علاجية مجففة بالتبريد تتعلق بالعصارة الهضمية
|
CA2651567A1
(en)
*
|
2006-05-09 |
2007-11-22 |
Genentech, Inc. |
Binding polypeptides with optimized scaffolds
|
US20080014589A1
(en)
|
2006-05-11 |
2008-01-17 |
Link Darren R |
Microfluidic devices and methods of use thereof
|
US9562837B2
(en)
|
2006-05-11 |
2017-02-07 |
Raindance Technologies, Inc. |
Systems for handling microfludic droplets
|
CA2652570A1
(en)
*
|
2006-05-15 |
2007-11-22 |
Viral Logic Systems Technology Corp. |
Cd47 related compositions and methods for treating immunological diseases and disorders
|
US8377448B2
(en)
*
|
2006-05-15 |
2013-02-19 |
The Board Of Trustees Of The Leland Standford Junior University |
CD47 related compositions and methods for treating immunological diseases and disorders
|
WO2007146023A1
(en)
*
|
2006-06-06 |
2007-12-21 |
Massachusetts Institute Of Technology |
Cholesterol-regulating complex of sirt1 and lxr and methods of use
|
US7981425B2
(en)
|
2006-06-19 |
2011-07-19 |
Amgen Inc. |
Thrombopoietic compounds
|
AT503861B1
(de)
|
2006-07-05 |
2008-06-15 |
F Star Biotech Forsch & Entw |
Verfahren zur manipulation von t-zell-rezeptoren
|
AT503889B1
(de)
|
2006-07-05 |
2011-12-15 |
Star Biotechnologische Forschungs Und Entwicklungsges M B H F |
Multivalente immunglobuline
|
AT503902B1
(de)
|
2006-07-05 |
2008-06-15 |
F Star Biotech Forsch & Entw |
Verfahren zur manipulation von immunglobulinen
|
EP2077912B1
(de)
|
2006-08-07 |
2019-03-27 |
The President and Fellows of Harvard College |
Fluorkohlenstoffemulsionsstabilisierende tenside
|
US8586006B2
(en)
|
2006-08-09 |
2013-11-19 |
Institute For Systems Biology |
Organ-specific proteins and methods of their use
|
US20100297103A1
(en)
|
2006-09-14 |
2010-11-25 |
Medical & Biological Laboratories Co., Ltd. |
Antibody having enhanced adcc activity and method for production thereof
|
MX2009003774A
(es)
|
2006-10-12 |
2009-04-22 |
Genentech Inc |
Anticuerpos para linfotoxina-alfa.
|
US20090068110A1
(en)
*
|
2006-12-22 |
2009-03-12 |
Genentech, Inc. |
Antibodies to insulin-like growth factor receptor
|
TW201206954A
(en)
*
|
2007-02-02 |
2012-02-16 |
Amgen Inc |
Hepcidin, hepcidin antagonists and methods of use
|
US8772046B2
(en)
|
2007-02-06 |
2014-07-08 |
Brandeis University |
Manipulation of fluids and reactions in microfluidic systems
|
CA2676766A1
(en)
|
2007-02-09 |
2008-08-21 |
Genentech, Inc. |
Anti-robo4 antibodies and uses therefor
|
US7875431B2
(en)
|
2007-02-22 |
2011-01-25 |
Genentech, Inc. |
Methods for detecting inflammatory bowel disease
|
US8592221B2
(en)
|
2007-04-19 |
2013-11-26 |
Brandeis University |
Manipulation of fluids, fluid components and reactions in microfluidic systems
|
AU2007353779B2
(en)
*
|
2007-05-17 |
2013-11-07 |
Genentech, Inc. |
Crystal structures of neuropilin fragments and neuropilin-antibody complexes
|
JP5602625B2
(ja)
|
2007-06-26 |
2014-10-08 |
エフ−スター ビオテヒノロギッシェ フォルシュングス− ウント エントヴィッケルングスゲゼルシャフト ミット ベシュレンクテル ハフツング |
結合物質のディスプレイ
|
TW200918089A
(en)
|
2007-07-16 |
2009-05-01 |
Genentech Inc |
Humanized anti-CD79b antibodies and immunoconjugates and methods of use
|
JP5469600B2
(ja)
|
2007-07-16 |
2014-04-16 |
ジェネンテック, インコーポレイテッド |
抗CD79b抗体及びイムノコンジュゲートとその使用方法
|
ES2614735T3
(es)
|
2007-07-23 |
2017-06-01 |
Janssen Biotech, Inc. |
Métodos y composiciones para tratar los trastornos relacionados con fibrosis usando antagonistas de la IL-17
|
EP2200631A1
(de)
|
2007-10-16 |
2010-06-30 |
Zymogenetics, Inc. |
Kombination aus blys-hemmung und anti-cd20-wirkstoffen zur behandlung von autoimmunerkrankungen
|
BRPI0819743A2
(pt)
|
2007-11-20 |
2014-10-07 |
Pioneer Hi Bred Int |
Ácido nucléico isolado, cassete de expressão, célula hospedeira, planta transgênica, semente transgênica, método para modular a resposta de etileno em uma planta, proteína isolada
|
AR069501A1
(es)
*
|
2007-11-30 |
2010-01-27 |
Genentech Inc |
Anticuerpos anti- vegf (factor de crecimiento endotelial vascular)
|
EP2078750B1
(de)
*
|
2008-01-09 |
2016-09-28 |
Ludwig-Maximilians-Universität München |
Fluoreszenter Zwei-Hybrid(F2H)-Assay zur direkten Sichtbarmachung von Proteininteraktionen in lebenden Zellen
|
AU2009206306B2
(en)
|
2008-01-25 |
2013-06-06 |
Amgen Inc. |
Ferroportin antibodies and methods of use
|
SI2657253T1
(sl)
|
2008-01-31 |
2017-10-30 |
Genentech, Inc. |
Protitelesa proti CD79b in imunokonjugati in postopki za uporabo
|
US20090233809A1
(en)
*
|
2008-03-04 |
2009-09-17 |
Affymetrix, Inc. |
Resequencing methods for identification of sequence variants
|
EP2816059A1
(de)
|
2008-05-01 |
2014-12-24 |
Amgen, Inc |
Anti-Hepcidin-Antikörper und Verfahren zu ihrer Verwendung
|
EP2113255A1
(de)
|
2008-05-02 |
2009-11-04 |
f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. |
Zytotoxisches Immunglobulin
|
EP2319869B1
(de)
|
2008-06-20 |
2016-08-17 |
National University Corporation Okayama University |
ANTIKÖRPER GEGEN DEN OXIDIERTES LDL/ß²GPI-KOMPLEX UND ANWENDUNG DAVON
|
EP2671891A3
(de)
|
2008-06-27 |
2014-03-05 |
Amgen Inc. |
Ang-2-Hemmung zur Behandlung von Multipler Sklerose
|
WO2010009365A1
(en)
|
2008-07-18 |
2010-01-21 |
Raindance Technologies, Inc. |
Droplet libraries
|
US9182406B2
(en)
*
|
2008-08-04 |
2015-11-10 |
Biodesy, Inc. |
Nonlinear optical detection of molecules comprising an unnatural amino acid possessing a hyperpolarizability
|
US8563697B2
(en)
|
2008-08-14 |
2013-10-22 |
Cephalon Australia Pty. Ltd. |
Anti-IL-12/IL-23 antibodies
|
AU2009307249B2
(en)
|
2008-10-20 |
2012-11-01 |
Gwangju Institute Of Science And Technology |
Bipodal peptide binder
|
CA2741834C
(en)
|
2008-10-31 |
2022-04-05 |
Centocor Ortho Biotech Inc. |
Fibronectin type iii domain based scaffold compositions, methods and uses
|
EP2358746B1
(de)
|
2008-11-03 |
2020-09-16 |
Molecular Partners AG |
Bindungsproteine zum hemmen der vegf-a-rezeptorinteraktion
|
SI2376535T1
(sl)
|
2008-12-09 |
2017-07-31 |
F. Hoffmann-La Roche Ag |
Protitelesa anti-pd-l1 in njihova uporaba za izboljšanje funkcije celic t
|
CA2750922A1
(en)
*
|
2009-01-28 |
2010-08-05 |
Antigen Express, Inc. |
Li-key hybrid peptides that modulate the immune response to influenza
|
EP2396011B1
(de)
|
2009-02-12 |
2016-04-13 |
Janssen Biotech, Inc. |
Auf fibronectin-typ-iii-domain basierende gerüstzusammensetzungen, verfahren und anwendung
|
WO2010101818A1
(en)
|
2009-03-02 |
2010-09-10 |
Pioneer Hi-Bred International, Inc. |
Nac transcriptional activators involved in abiotic stress tolerance
|
US8528589B2
(en)
|
2009-03-23 |
2013-09-10 |
Raindance Technologies, Inc. |
Manipulation of microfluidic droplets
|
AU2010236787A1
(en)
|
2009-04-01 |
2011-11-10 |
Genentech, Inc. |
Anti-FcRH5 antibodies and immunoconjugates and methods of use
|
EP2272939B1
(de)
|
2009-07-03 |
2012-09-12 |
BP Corporation North America Inc. |
Alken-Oligomerisierungsverfahren
|
US20110035843A1
(en)
|
2009-08-05 |
2011-02-10 |
Pioneer Hi-Bred International, Inc. |
Novel eto1 genes and use of same for reduced ethylene and improved stress tolerance in plants
|
US8926976B2
(en)
|
2009-09-25 |
2015-01-06 |
Xoma Technology Ltd. |
Modulators
|
US9885711B2
(en)
|
2009-09-25 |
2018-02-06 |
Xoma Technology Ltd. |
Screening methods
|
EP2486409A1
(de)
|
2009-10-09 |
2012-08-15 |
Universite De Strasbourg |
Markiertes nanomaterial auf siliziumbasis mit verbesserten eigenschaften und seine verwendung
|
BR112012009409A2
(pt)
|
2009-10-22 |
2017-02-21 |
Genentech Inc |
método de identificação de uma substância inibidora, molécula antagonista, ácido nucleico isolado, vetor, célula hospedeira, método para fabricar a molécula, composição, artigo de fabricação, método de inibição de uma atividade biológica, método de tratamento de uma condição patológica, método para detectar msp em uma amostra e método para detectar hepsina em uma amostra
|
AR079217A1
(es)
|
2009-11-30 |
2012-01-04 |
Genentech Inc |
Composiciones y metodos para el diagnostico y el tratamiento de tumores
|
JP2013512672A
(ja)
|
2009-12-02 |
2013-04-18 |
アムジエン・インコーポレーテツド |
ヒトFGFR1c、ヒトβ−クロト−、ならびにヒトFGFR1cおよびヒトβ−クロト−の両方に結合する結合タンパク質
|
US10837883B2
(en)
|
2009-12-23 |
2020-11-17 |
Bio-Rad Laboratories, Inc. |
Microfluidic systems and methods for reducing the exchange of molecules between droplets
|
CN102933231B
(zh)
|
2010-02-10 |
2015-07-29 |
伊缪诺金公司 |
Cd20抗体及其用途
|
WO2011100604A2
(en)
|
2010-02-12 |
2011-08-18 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US9399797B2
(en)
|
2010-02-12 |
2016-07-26 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US9366632B2
(en)
|
2010-02-12 |
2016-06-14 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US10351905B2
(en)
|
2010-02-12 |
2019-07-16 |
Bio-Rad Laboratories, Inc. |
Digital analyte analysis
|
JP5981853B2
(ja)
|
2010-02-18 |
2016-08-31 |
ジェネンテック, インコーポレイテッド |
ニューレグリンアンタゴニスト及び癌の治療におけるそれらの使用
|
MX2012009215A
(es)
|
2010-02-23 |
2012-11-23 |
Genentech Inc |
Composiciones y metodos para el diagnostico y tratamiento de tumores.
|
TWI510246B
(zh)
|
2010-04-30 |
2015-12-01 |
Molecular Partners Ag |
抑制vegf-a受體交互作用的經修飾結合性蛋白質
|
MA34291B1
(fr)
|
2010-05-03 |
2013-06-01 |
Genentech Inc |
Compositions et méthodes de diagnostic et de traitement d'une tumeur
|
NZ605449A
(en)
|
2010-07-09 |
2015-03-27 |
Genentech Inc |
Anti-neuropilin antibodies and methods of use
|
WO2012009705A1
(en)
|
2010-07-15 |
2012-01-19 |
Zyngenia, Inc. |
Ang-2 binding complexes and uses thereof
|
EP3447155A1
(de)
|
2010-09-30 |
2019-02-27 |
Raindance Technologies, Inc. |
Sandwichassays in tröpfchen
|
KR20140032356A
(ko)
|
2010-11-26 |
2014-03-14 |
몰리큘라 파트너스 아게 |
설계된 안키린 반복 단백질에 대한 개선된 n-말단 캡핑 모듈
|
EP2474612A1
(de)
|
2011-01-05 |
2012-07-11 |
University College Dublin, National University of Ireland Dublin |
Affinitätstrennungsmittel und ihre Verwendungen zur Trennung, Reinigung und Konzentration von Zielmolekülen
|
US9005909B2
(en)
|
2011-01-06 |
2015-04-14 |
Rigel Pharmaceuticals, Inc. |
Whole blood assay for measuring AMPK activation
|
WO2012109600A2
(en)
|
2011-02-11 |
2012-08-16 |
Raindance Technologies, Inc. |
Methods for forming mixed droplets
|
US20140088019A1
(en)
|
2011-02-11 |
2014-03-27 |
Zyngenia, Inc. |
Monovalent and Multivalent Multispecific Complexes and Uses Thereof
|
WO2012112804A1
(en)
|
2011-02-18 |
2012-08-23 |
Raindance Technoligies, Inc. |
Compositions and methods for molecular labeling
|
WO2012129347A1
(en)
|
2011-03-21 |
2012-09-27 |
Biodesy, Llc |
Classification of kinase inhibitors using nonlinear optical techniques
|
WO2012149439A2
(en)
|
2011-04-29 |
2012-11-01 |
Janssen Biotech, Inc. |
Il4/il13 binding repeat proteins and uses
|
EP3263127B1
(de)
|
2011-05-23 |
2019-08-21 |
Yeda Research and Development Co. Ltd |
Verwendung einer akt-phosphorylierung als biomarker zur prognose neurodegenerativer erkrankungen und zur behandlung davon
|
EP2714738B1
(de)
|
2011-05-24 |
2018-10-10 |
Zyngenia, Inc. |
Multivalente und monovalente multispezifische komplexe und ihre verwendungen
|
US8841071B2
(en)
|
2011-06-02 |
2014-09-23 |
Raindance Technologies, Inc. |
Sample multiplexing
|
US8658430B2
(en)
|
2011-07-20 |
2014-02-25 |
Raindance Technologies, Inc. |
Manipulating droplet size
|
KR20140068062A
(ko)
|
2011-09-15 |
2014-06-05 |
제넨테크, 인크. |
분화의 촉진 방법
|
KR20140084164A
(ko)
|
2011-10-15 |
2014-07-04 |
제넨테크, 인크. |
암의 치료를 위한 scd1 길항제
|
BR112014009968A2
(pt)
|
2011-10-25 |
2017-07-04 |
Du Pont |
método para redução do teor de acetato, arabinosidase e/ou ferulato em uma planta, método de modulação da concentração de carboidratos da planta em uma planta transgénica, método para alterar o teor de acetila e de reticulação nos tecidos das plantas, método para a produção de biomassa para a produção de biocombustíveis ou silagem, produto, forragem de planta
|
WO2013096926A1
(en)
|
2011-12-22 |
2013-06-27 |
Glycomimetics, Inc. |
E-selectin antagonist compounds, compositions, and methods of use
|
CN104168920A
(zh)
|
2012-01-18 |
2014-11-26 |
霍夫曼-拉罗奇有限公司 |
使用fgf19调控剂的方法
|
BR112014019741A2
(pt)
|
2012-02-11 |
2020-12-22 |
Genentech, Inc |
Usos de um antagonista da via wnt, uso de uma terapia anticâncer, método de identificação de um indivíduo com câncer, métodos para prever, método de inibição da proliferação de uma célula de câncer, uso de um antagonista da translocação de r-spondina e antagonista da translocação de r-spondina isolado
|
MX2014010953A
(es)
|
2012-03-16 |
2014-10-13 |
Hoffmann La Roche |
Metodos para tratamiento de melanoma con inhibidores pak1.
|
KR20140142293A
(ko)
|
2012-03-16 |
2014-12-11 |
제넨테크, 인크. |
조작된 입체형태적으로-안정화된 단백질
|
US9139863B2
(en)
|
2012-03-16 |
2015-09-22 |
Genentech, Inc. |
Engineered conformationally-stabilized proteins
|
CN106290917B
(zh)
|
2012-04-25 |
2020-06-05 |
比奥德赛公司 |
用于检测蛋白质的变构调节剂的方法
|
WO2013170191A1
(en)
|
2012-05-11 |
2013-11-14 |
Genentech, Inc. |
Methods of using antagonists of nad biosynthesis from nicotinamide
|
CN104508129A
(zh)
|
2012-06-28 |
2015-04-08 |
分子伴侣公司 |
设计的与血小板衍生生长因子结合的锚蛋白重复序列蛋白
|
EP2738180A1
(de)
|
2012-11-30 |
2014-06-04 |
Molecular Partners AG |
Bindeproteine mit mindestens zwei Bindedomänen gegen HER2
|
LT2928476T
(lt)
|
2012-12-07 |
2018-05-25 |
Glycomimetics, Inc. |
Junginiai, kompozicijos ir būdai, naudojant e-selektino antagonistus, hemopoetinių ląstelių mobilizacijai
|
JP2016509045A
(ja)
|
2013-02-22 |
2016-03-24 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
がんを治療し、薬剤耐性を防止する方法
|
US9925240B2
(en)
|
2013-03-06 |
2018-03-27 |
Genentech, Inc. |
Methods of treating and preventing cancer drug resistance
|
JOP20140087B1
(ar)
|
2013-03-13 |
2021-08-17 |
Amgen Inc |
بروتينات مخصصة ل baff و b7rp1 وإستخداماتها
|
US9458246B2
(en)
|
2013-03-13 |
2016-10-04 |
Amgen Inc. |
Proteins specific for BAFF and B7RP1
|
CA2905070A1
(en)
|
2013-03-14 |
2014-09-25 |
Genentech, Inc. |
Methods of treating cancer and preventing cancer drug resistance
|
EP2972373B1
(de)
|
2013-03-15 |
2019-10-09 |
F.Hoffmann-La Roche Ag |
Biomarker und verfahren zur behandlung von pd-1 und pd-l1-verwandten leiden
|
WO2014152507A2
(en)
|
2013-03-15 |
2014-09-25 |
Pioneer Hi-Bred International, Inc. |
Modulation of acc deaminase expression
|
EA201890895A1
(ru)
|
2013-03-15 |
2019-02-28 |
Зинджения, Инк. |
Мультивалентные и моновалентные мультиспецифические комплексы и их применение
|
MX2015011899A
(es)
|
2013-03-15 |
2016-05-05 |
Genentech Inc |
Metodos para el tratamiento de cáncer y prevención de resistencia a los fármacos para el cáncer.
|
JP6440055B2
(ja)
*
|
2013-05-10 |
2018-12-19 |
国立大学法人 東京大学 |
ペプチドライブラリの製造方法、ペプチドライブラリ、及びスクリーニング方法
|
WO2014201265A1
(en)
|
2013-06-14 |
2014-12-18 |
Pacific Biosciences Of California, Inc. |
Bis-biotinylation tags
|
US11901041B2
(en)
|
2013-10-04 |
2024-02-13 |
Bio-Rad Laboratories, Inc. |
Digital analysis of nucleic acid modification
|
US9944977B2
(en)
|
2013-12-12 |
2018-04-17 |
Raindance Technologies, Inc. |
Distinguishing rare variations in a nucleic acid sequence from a sample
|
PL3712174T3
(pl)
|
2013-12-24 |
2022-07-04 |
Janssen Pharmaceutica Nv |
Przeciwciała i fragmenty anty-vista
|
EP3090063B1
(de)
|
2013-12-31 |
2019-11-06 |
Bio-Rad Laboratories, Inc. |
Verfahren zur detektion von latentem retrovirus
|
MX2016009753A
(es)
|
2014-01-28 |
2017-07-07 |
Buck Inst For Res On Aging |
Metodos y composiciones para exterminar celulas senescentes y para tratar enfermedades y trastornos asociados con la senectud.
|
WO2015116902A1
(en)
|
2014-01-31 |
2015-08-06 |
Genentech, Inc. |
G-protein coupled receptors in hedgehog signaling
|
CA3225091A1
(en)
|
2014-05-05 |
2015-11-12 |
Regeneron Pharmaceuticals, Inc. |
Humanized c5 and c3 animals
|
CN106661622B
(zh)
|
2014-05-23 |
2020-08-21 |
豪夫迈·罗氏有限公司 |
Mit生物标志物和使用它们的方法
|
PT3628680T
(pt)
|
2014-06-12 |
2021-10-07 |
Ra Pharmaceuticals Inc |
Modulação da atividade do complemento
|
JP2017517552A
(ja)
|
2014-06-13 |
2017-06-29 |
ジェネンテック, インコーポレイテッド |
抗癌剤耐性の治療及び防止方法
|
US10562946B2
(en)
|
2014-06-20 |
2020-02-18 |
Genentech, Inc. |
Chagasin-based scaffold compositions, methods, and uses
|
EP3237906B8
(de)
|
2014-12-23 |
2020-10-28 |
Bluelight Therapeutics, Inc. |
Befestigung von proteinen an schnittstellen zur verwendung in nicht-linearer optischer detektion
|
JP6640229B2
(ja)
|
2015-01-28 |
2020-02-05 |
ラ ファーマシューティカルズ インコーポレイテッドRa Pharmaceuticals,Inc. |
補体活性の変調剤
|
MX2017012679A
(es)
|
2015-04-06 |
2018-02-09 |
Subdomain Llc |
Polipeptidos que contienen dominios de union de novo y usos de los mismos.
|
CN107787332B
(zh)
|
2015-04-24 |
2022-09-09 |
豪夫迈·罗氏有限公司 |
多特异性抗原结合蛋白
|
JP7026509B2
(ja)
|
2015-06-24 |
2022-02-28 |
ヤンセン ファーマシューティカ エヌブイ |
抗vista抗体およびフラグメント
|
US10647981B1
(en)
|
2015-09-08 |
2020-05-12 |
Bio-Rad Laboratories, Inc. |
Nucleic acid library generation methods and compositions
|
WO2017053807A2
(en)
|
2015-09-23 |
2017-03-30 |
Genentech, Inc. |
Optimized variants of anti-vegf antibodies
|
MX2018007352A
(es)
|
2015-12-16 |
2019-05-16 |
Ra Pharmaceuticals Inc |
Moduladores de la actividad del complemento.
|
EP3405478A4
(de)
|
2015-12-23 |
2019-10-30 |
Moonshot Pharma LLC |
Verfahren zur induzierung einer immunantwort durch hemmung von nonsense-vermitteltem zerfall
|
JP2019518017A
(ja)
|
2016-02-09 |
2019-06-27 |
アレクサンダー・クランツ |
トレースレス親和性標識を使用したタンパク質の部位選択的官能化
|
CN116920085A
(zh)
|
2016-02-12 |
2023-10-24 |
詹森药业有限公司 |
抗-vista(b7h5)抗体
|
AU2017241776A1
(en)
|
2016-03-29 |
2018-10-11 |
Janssen Biotech, Inc. |
Treating psoriasis with increased interval dosing of anti-IL12 and/or -23 antibody
|
WO2017175058A1
(en)
|
2016-04-07 |
2017-10-12 |
Janssen Pharmaceutica Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
EP3484927A1
(de)
|
2016-07-15 |
2019-05-22 |
Poseida Therapeutics, Inc. |
Für muc1 spezifische chimäre antigenrezeptoren (autos) und verfahren zu deren verwendung
|
US20190177421A1
(en)
|
2016-07-15 |
2019-06-13 |
Poseida Therapeutics, Inc. |
Chimeric antigen receptors and methods for use
|
JP2019534858A
(ja)
|
2016-09-09 |
2019-12-05 |
ジェネンテック, インコーポレイテッド |
Frizzledの選択的ペプチド阻害剤
|
MX2019003703A
(es)
|
2016-09-30 |
2020-08-13 |
Janssen Biotech Inc |
Método seguro y eficaz para tratar la psoriasis con el anticuerpo específico anti-il23.
|
AU2017362222A1
(en)
|
2016-11-16 |
2019-05-30 |
Janssen Biotech, Inc. |
Method of treating psoriasis with anti-IL-23 specific antibody
|
MX2019006527A
(es)
|
2016-12-07 |
2019-08-01 |
Ra Pharmaceuticals Inc |
Moduladores de la actividad del complemento.
|
CA3052095A1
(en)
|
2017-01-30 |
2018-08-02 |
Janssen Biotech, Inc. |
Anti-tnf antibodies, compositions, and methods for the treatment of active psoriatic arthritis
|
MA47442A
(fr)
|
2017-02-07 |
2019-12-18 |
Janssen Biotech Inc |
Anticorps anti-tnf, compositions et méthodes pour le traitement de la spondylarthrite ankylosante active
|
WO2018152496A1
(en)
|
2017-02-17 |
2018-08-23 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Compositions and methods for the diagnosis and treatment of zika virus infection
|
AU2018225745B2
(en)
|
2017-02-27 |
2023-12-07 |
Regeneron Pharmaceuticals, Inc. |
Humanized model of kidney and liver disorders
|
WO2018169948A1
(en)
|
2017-03-13 |
2018-09-20 |
Poseida Therapeutics, Inc. |
Compositions and methods for selective elimination and replacement of hematopoietic stem cells
|
JP7248588B2
(ja)
|
2017-04-21 |
2023-03-29 |
ジェネンテック, インコーポレイテッド |
疾患の治療のためのklk5アンタゴニストの使用
|
EP3615569A1
(de)
|
2017-04-25 |
2020-03-04 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Antikörper und verfahren zur diagnose und behandlung von epstein-barr-virus-infektionen
|
JP2020525434A
(ja)
|
2017-06-22 |
2020-08-27 |
ムーンショット ファーマ エルエルシー |
アンレキサノクス及び免疫調節剤を含む組成物で癌を治療する方法
|
CN111094334A
(zh)
|
2017-07-19 |
2020-05-01 |
美国卫生与公众服务部 |
用于诊断和治疗乙肝病毒感染的抗体和方法
|
JP2020532987A
(ja)
|
2017-09-08 |
2020-11-19 |
ポセイダ セラピューティクス,インコーポレイティド |
キメラリガンド受容体(clr)介在性の条件遺伝子発現のための組成物および方法
|
TW201922780A
(zh)
|
2017-09-25 |
2019-06-16 |
美商健生生物科技公司 |
以抗il12/il23抗體治療狼瘡之安全且有效之方法
|
CA3078460A1
(en)
|
2017-10-04 |
2019-04-11 |
Opko Pharmaceuticals, Llc |
Articles and methods directed to personalized therapy of cancer
|
EP3703676A4
(de)
|
2017-11-04 |
2021-12-15 |
Advanced Proteome Therapeutics, Inc. |
Zusammensetzung und verfahren zur modifizierung von polypeptiden
|
EP3728321A1
(de)
|
2017-12-22 |
2020-10-28 |
F. Hoffmann-La Roche AG |
Verwendung von pilra-bindenden mitteln zur behandlung einer erkrankung
|
WO2019150309A1
(en)
|
2018-02-02 |
2019-08-08 |
Hammack Scott |
Modulators of gpr68 and uses thereof for treating and preventing diseases
|
US20190345245A1
(en)
|
2018-05-11 |
2019-11-14 |
Janssen Biotech, Inc. |
Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
|
WO2020016838A2
(en)
|
2018-07-18 |
2020-01-23 |
Janssen Biotech, Inc. |
Sustained response predictors after treatment with anti-il23 specific antibody
|
KR102090402B1
(ko)
|
2018-10-31 |
2020-03-17 |
공주대학교 산학협력단 |
탈실리카된 펜타실구조형 제올라이트 촉매를 이용한 부텐으로부터 고급 알켄 제조방법
|
WO2020104943A2
(en)
|
2018-11-20 |
2020-05-28 |
Janssen Biotech, Inc. |
Safe and effective method of treating psoriasis with anti-il-23 specific antibody
|
US20200197517A1
(en)
|
2018-12-18 |
2020-06-25 |
Janssen Biotech, Inc. |
Safe and Effective Method of Treating Lupus with Anti-IL12/IL23 Antibody
|
WO2020132396A1
(en)
|
2018-12-20 |
2020-06-25 |
Poseida Therapeutics, Inc. |
Nanotransposon compositions and methods of use
|
EP3938392A1
(de)
|
2019-03-14 |
2022-01-19 |
Janssen Biotech, Inc. |
Verfahren zur herstellung von anti-tnf-antikörperzusammensetzungen
|
EP3938391A1
(de)
|
2019-03-14 |
2022-01-19 |
Janssen Biotech, Inc. |
Verfahren zur herstellung von anti-tnf-antikörperzusammensetzungen
|
CN113840838A
(zh)
|
2019-03-14 |
2021-12-24 |
詹森生物科技公司 |
用于产生抗tnf抗体组合物的制造方法
|
KR20210141583A
(ko)
|
2019-03-18 |
2021-11-23 |
얀센 바이오테크 인코포레이티드 |
항-il-12/il-23 항체를 사용한 소아 대상의 건선 치료 방법
|
WO2020198731A2
(en)
|
2019-03-28 |
2020-10-01 |
Danisco Us Inc |
Engineered antibodies
|
KR20220005568A
(ko)
|
2019-05-09 |
2022-01-13 |
제넨테크, 인크. |
항체의 제조 방법
|
JP2022534020A
(ja)
|
2019-05-23 |
2022-07-27 |
ヤンセン バイオテツク,インコーポレーテツド |
Il-23及びtnfアルファに対する抗体の併用療法による炎症性腸疾患の治療方法
|
MX2021014882A
(es)
|
2019-06-03 |
2022-03-25 |
Janssen Biotech Inc |
Anticuerpos anti-tnf, composiciones y métodos para el tratamiento de la espondilitis anquilosante activa.
|
EP3976648A1
(de)
|
2019-06-03 |
2022-04-06 |
Janssen Biotech, Inc. |
Anti-tnf-antikörperzusammensetzungen und verfahren zur behandlung von aktiver psoriasis-arthritis
|
CN114761424A
(zh)
|
2019-09-05 |
2022-07-15 |
波赛达治疗公司 |
同种异体细胞组合物和使用方法
|
AU2020407235A1
(en)
|
2019-12-20 |
2022-07-07 |
Poseida Therapeutics, Inc. |
Anti-MUC1 compositions and methods of use
|
WO2021183795A1
(en)
|
2020-03-11 |
2021-09-16 |
Poseida Therapeutics, Inc. |
Chimeric stimulatory receptors and methods of use in t cell activation and differentiation
|
IL297025A
(en)
|
2020-04-14 |
2022-12-01 |
Poseida Therapeutics Inc |
Preparations and methods for use in cancer treatment
|
WO2021221783A1
(en)
|
2020-05-01 |
2021-11-04 |
Massachusetts Institute Of Technology |
Methods for identifying chimeric antigen receptor-targeting ligands and uses thereof
|
WO2021221782A1
(en)
|
2020-05-01 |
2021-11-04 |
Massachusetts Institute Of Technology |
Chimeric antigen receptor-targeting ligands and uses thereof
|
US20240000969A1
(en)
|
2020-10-21 |
2024-01-04 |
Poseida Therapeutics San Diego |
Compositions and methods for delivery of nucleic acids
|
US20230042465A1
(en)
|
2021-07-09 |
2023-02-09 |
Janssen Biotech, Inc. |
Manufacturing Methods for Producing Anti-TNF Antibody Compositions
|
AU2022306144A1
(en)
|
2021-07-09 |
2024-02-22 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-tnf antibody compositions
|
AU2022360244A1
(en)
|
2021-10-04 |
2024-04-11 |
Poseida Therapeutics, Inc. |
Transposon compositions and methods of use thereof
|
WO2023073615A1
(en)
|
2021-10-29 |
2023-05-04 |
Janssen Biotech, Inc. |
Methods of treating crohn's disease with anti-il23 specific antibody
|
WO2023141576A1
(en)
|
2022-01-21 |
2023-07-27 |
Poseida Therapeutics, Inc. |
Compositions and methods for delivery of nucleic acids
|
WO2023187707A1
(en)
|
2022-03-30 |
2023-10-05 |
Janssen Biotech, Inc. |
Method of treating mild to moderate psoriasis with il-23 specific antibody
|
WO2023205334A1
(en)
*
|
2022-04-20 |
2023-10-26 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Coupling assay for t cell specificity (cats) and method of its use
|
WO2023223265A1
(en)
|
2022-05-18 |
2023-11-23 |
Janssen Biotech, Inc. |
Method for evaluating and treating psoriatic arthritis with il23 antibody
|